Results 211 to 220 of about 8,406,316 (344)

Assessing quality of life in cancer patients

, 1989
Peter Maguire, Peter J. Selby
openalex   +2 more sources

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Quality of life and well-being in Colombian centenarians. [PDF]

Sci Rep
Anaya JM, Alpi SV, Castelblanco-Toro SM, Lozada-Martínez ID, Salazar-Uribe JC.   +4 more
europepmc   +1 more source

The Pennsylvania domiciliary care experiment: I. Impact on quality of life.

, 1983
S. Sherwood, John N. Morris
openalex   +2 more sources

Domiciliary nocturnal nasal intermittent positive pressure ventilation in hypercapnic respiratory failure due to chronic obstructive lung disease: effects on sleep and quality of life. [PDF]

, 1992
Mark Elliott, Anita K. Simonds, M.P. Carroll, Jadwiga A. Wedzicha, M A Branthwaite   +4 more
openalex   +1 more source

Quality of life

European Journal of Vascular and Endovascular Surgery, 1996
openaire   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

Quality of life of patients with allergic rhinitis

Family Medicine & Primary Care Review, 2015
Marzanna Stanisławska, Krystyna Iwanowska, Anna Jurczak, Artur Kotwas, Jolanta Jelińska, Jacek Brodowski, Elżbieta Grochans   +6 more
doaj   +1 more source

Depression and Anxiety as Predictors of Quality of Life in Osteoarthritis Patients. [PDF]

Cureus
Mashayekhi Y, Baba-Aissa S, Assefa AK, Mutamba FT, Nur AM, Shahid ZY, Salimon NM, Habahbeh A, Ali N, Shandi IM, Al Niazi R, Habib F.   +11 more
europepmc   +1 more source

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

Molecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun‐Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng, Young Joo Park, Jong‐Il Kim   +11 more
wiley   +1 more source